Medication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration

Similar documents
POLICY. Clinician is any health care professional accepting responsibility for care of patients and their medications.

Objectives MEDICATION SAFETY & TECHNOLOGY. Disclosure. How has technology improved the way we dispense and compound medications AdminRx AcuDose Rx

To prevent harm to patients from adverse medication events involving high-alert medications.

Safe Medication Practices

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

INQUEST INTO THE DEATH OF: MARIE TANNER

Reducing the risk of serious medication errors in community pharmacy practice

The Joint Commission Medication Management Update for 2010

High-Alert Medications (HAM)

REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY

Current Status: Active PolicyStat ID:

Medication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003

FIRST PATIENT SAFETY ALERT FROM NATIONAL PATIENT SAFETY AGENCY (NPSA) Preventing accidental overdose of intravenous potassium

Improving Safety Practices Anticoagulation Therapy

Re-Engineering Medication Processes to Capitalize on Technology. Jane Englebright, PhD, RN Vice President, Quality HCA

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance

The Joint Commission Medication Management Update for 2010

(10+ years since IOM)

Objectives. Demographics: Type and Services 1/22/2014. ICAHN Aggregate Results. ISMP Medication Safety Self Assessment for Hospitals

Nurse Orientation. Medication Management

Medication Safety in LTC. Objectives. About ISMP Canada

Safe Medication Management Practices 2017/2018

N ATIONAL Q UALITY F ORUM. Safe Practices for Better Healthcare 2006 Update A CONSENSUS REPORT

JCAHO Med Management

A shortage of everything except ERRORS

Objectives. Key Elements. ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management 5/20/2014

Considerations for Sterile Compounding of Parenteral Products for Pediatric Use: Part 2 PharMEDium Lunch and Learn Series LUNCH AND LEARN

Constant Pursuit of Medication Safety. Geraldine Koh Chief Pharmacist

Medication Safety Issues and Recommended Strategies Related to Sterile Compounding PharMEDium Lunch and Learn Series LUNCH AND LEARN

Never Events in Healthcare

Drug Events. Adverse R EDUCING MEDICATION ERRORS. Survey Adapted from Information Developed by HealthInsight, 2000.

Recommendations from National Patient Safety Agency alerts that remain relevant to the Never Events list 2018

Patient Safety and Quality Measures for CRRT: The UAB Experience. Ashita Tolwani, M.D. University of Alabama at Birmingham CRRT 2012

Improving the Patient Experience Through Pharmacy

1. Medical Errors: The Scope of the Problem

Medication Use Evaluation and Cost Minimization Analysis of Injectable Nicardipine in a Community Hospital

Medication Safety Technology The Good, the Bad and the Unintended Consequences

WHAT are medication errors?

Anatomy of a Fatal Medication Error

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

The International Patient Safety Goals

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014

Adverse Drug Events in Wyoming

Medication Storage and Security: The #1 Non- Complaint Medication Management Standard

IMPACT OF TECHNOLOGY ON MEDICATION SAFETY

Why is Critical Incident Reporting and Shared Learning Important for Patient Safety?

For Personal Use Only. Any commercial use is strictly prohibited.

Introducing ISMP s New Targeted Best Practices for

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST. Parenteral Concentrated Potassium and Sodium Policy

Sharp HealthCare Safety Training 2015 Module 3, Lesson 2 Always Events: Line and Tube Reconciliation and Guardrails Use

Culture of Safety: What s in Your Toolbox?

University of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation

Medication Errors An Opportunity to Improve

APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS

To describe the process for the management of an infusion pump involved in an adverse event or close call.

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Most of you flew to this meeting

Alabama Medicaid Pharmacy Override

Medication Safety Way Beyond the 5 Rights

A Game Plan to Surviving a Joint Commission Survey. May Adra, BS Pharm, PharmD, BCPS

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

Patient Safety for Pharmacy Technicians

Example of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen)

Profiles in CSP Insourcing: Tufts Medical Center

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016

Critical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital

9/29/2014. Disclosure: I, Amber Sanders have no financial relationship to disclose. Objectives. Medication Safety in Pediatric Populations

Arizona Department of Health Services Licensing and CMS Deficient Practices

High-Risk Medication Management Policy

Human Factors. Frank Federico, RPh. This presenter has nothing to disclose.

INSITE : Medication Management for Long-Term Care

CHAPTER 8 Hospital Accreditation

CRAIG HOSPITAL POLICY/PROCEDURE

Go! Guide: Medication Administration

Bar Code Medication Administration and MAR Resource Manual

Impact of an Innovative ADC System on Medication Administration

NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas

Session Objectives. Medication Errors in Adults and Children. Dennis Quaid American Society of Health- System Pharmacists (ASHP) Meeting December 2009

Pharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea

Prepublication Requirements

Safermeds Survey Report

Patient Safety (PS) 1) A collaborative process is used to develop policies and/or procedures that address the accuracy of patient identification.

PHARMACY SERVICES/MEDICATION USE

Parenteral Nutrition Drug Shortages

Preventing Adverse Drug Events and Harm

Ontario Hospital Critical Incidents Related to Medications or IV Fluids Analysis Report. October 2011 to December 2012

DERBY HOSPITALS NHS FOUNDATION TRUST PROJECT FINAL SUMMARY REPORT. Purchasing for Safety - Injectable Medicines

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months.

with the team that understands your drug delivery needs. Comprehensive solutions in drug delivery.

Presentation Outline

Definitions: In this chapter, unless the context or subject matter otherwise requires:

NORTH CAROLINA. Downloaded January 2011

Ch. 113 PHARMACY SERVICES 28 CHAPTER 113. PHARMACY SERVICES A. GENERAL PROVISIONS Cross References

Using Healthcare Failure Mode and Effect Analysis Tool to Review the Process of Ordering and Administrating Potassium Chloride and Potassium Phosphate

Unit dose requirements

HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals. One Year Later

PURPOSE To establish a standardized process for the activity of an independent double check for medication administration.

Transcription:

Medication Safety & Electrolyte Administration Jennifer Doughty, PharmD PGY2 Pharmacy Resident Emergency Medicine Stormont Vail Health, Topeka, KS Objectives Define and identify high alert medications Identify potential weaknesses / areas of concern Outline safe medication use recommendations Promote utilization of policy & procedures Encourage reporting of errors & near misses High Alert Medications The Institute of Safe Medication Practices (ISMP) defines high alert medications as: Drugs that bear a heightened risk of causing significant patient harm when used in error Mistakes may or may not be more common, but the consequences are clearly more devastating to patients Often impossible to reverse the effects of inappropriate electrolyte administration and could be deadly 1

ISMP High Alert Medications Adrenergic agonists Adrenergic antagonists Anesthetic agents Antiarrhythmics Anticoagulants Antithrombotics Cardioplegic solutions Chemotherapy agents Electrolytes & fluids Epidural & intrathecal meds Insulins & oral hypoglycemics Liposomal forms of drugs Narcotics/Opiates Neuromuscular blockers Parental nutrition preparations Radiocontrast agents Sedatives Common Examples Electrolyte solutions: Potassium chloride Potassium phosphates Calcium chloride Calcium gluconate Magnesium sulfate Sodium bicarbonate Sodium phosphate Non-isotonic fluids: Sodium chloride 3% Dextrose 50% Sterile water Create an Error Prevention Plan Create awareness Provide education and information to all healthcare personnel Identify problems Can be actual or potential problems Review adverse drug reaction reports Review literature Confer with a multidisciplinary group within your organization Make improvements 2

Create an Error Prevention Plan Goal: Prevent High Risk Medication Errors Results: Modify strategy as necessary Desired Outcome: Reduce poor patient outcomes Measure/Target: Assess data on med related error occurrences Strategy: 1. Identify weakness 2. Install Error Traps CREATE AWARENESS Raising Awareness High Risk Medications Lists: ISMP Institute for Safe Medication Practices JCAHO Joint Commission CMS Centers for Medicare and Medicaid Services Joint Commission requires healthcare organizations to: Maintain a policy of high risk medications for the institution Design safeguards to prevent medication errors 3

Differences in Perception 2014 ISMP survey of health care professionals that appropriately identified select high alert medications Medication Nurses Pharmacists Practitioner Concentrated Electrolytes 88.2% 91.2% 81.9% Chemotherapy 85.4% 86.8% 74.6% Insulin 86.7% 89.0% 65.5% Neuromuscular blockers 79.1% 84.6% 80.2% Anticoagulants 80.2% 75.7% 74.6% Opiates 71.0% 70.6% 62.7% Sedatives 57.8% 38.2% 53.7% Magnesium sulfate 49.9% 24.3% 27.1% Types of Errors 2014 ISMP survey of healthcare professionals the types of errors respondents reported involving high alert medications Types of Errors 2014 ISMP survey of healthcare professionals the types of errors respondents reported involving high alert medications 4

IDENTIFY PROBLEMS Reasons errors may occur Dosing errors Calculation errors Concentration errors IV admixture errors Duplicate therapy Look-alike/sound-alike drugs Adverse drug reactions (ADRs) Contamination Incompatibilities Areas of Potential Weakness Departments where workflow is fast-paced Emergency department Critical care Surgery Trauma Special concern for: Look-alike medications Sound-alike medications Concentrated medications 5

MAKE IMPROVEMENTS Ways to Make Improvements Implement fail-safes Add constraints Externalize error-prone processes Improve access to information Standardize Simplification Differentiation Reminders Redundancies Patient monitoring Failure mode and effects analysis Procurement Standardize: Order only standardized premixed bags of electrolytes Differentiate: Ensure there are no similarly packaged/labeled fluids Add reminders: Label all high alert meds with HIGH RISK warning labels 6

Storage Add Constraints: Remove concentrated electrolytes from patient care areas Store premixed bags only in the pharmacy or in locked automated dispensing cabinets Differentiate: Segregate the storage of electrolytes from other fluids Ordering Standardize: Implement hospital-wide electrolyte protocols for administration of ALL electrolytes Simplify: Utilize order sets or pre-printed orders for use with administration of IV electrolytes Add Constraints: Set dose limits for IV electrolyte administration Preparing Externalize error-prone processes: Eliminate the potential for preparation errors Use only standardized, manufactured, premixed bags of electrolytes and fluids 7

Dispensing Implement fail-safes: Utilize electronic medical records and automated dispensing cabinets, if possible Limit access to only pharmacy personnel for electrolyte dispensing, if possible If not possible, designate only certain individuals to have access to these medications (ex. Charge Nurse) Administration Implement fail-safes: Implement barcode scanning whenever possible Administer all IV electrolytes through rate-controlled programmable pumps Use smart pumps when available, do not bypass inputting all the information Redundancies: Utilize double checks (manual or automated) REPORTING 8

Report Errors Encourage reporting of near misses and errors You can t fix what you don t know is a problem! Create a culture of appreciation for error reporting Do not penalize individuals for speaking up Permit anonymous reporting Have open discussions with the healthcare team Discuss errors or near misses that have occurred Implement changes to prevent reoccurrence ELECTROLYTE PROTOCOLS General Recommendations Create a standardized protocol Utilize order sets or preprinted order forms Use standard concentrations of manufactured premixes Have an electrolyte level within previous 24 hours Never administer concentrated electrolytes Always dilute them and administer via IVPB on a pump Recheck electrolyte level after administration 9

Potassium IV Protocols Have a previous level from within 4 hours May recheck a level 4 hours after administration Central line administration Maximum rate: 20 meq IV over 1 hour Maximum concentration: 20 meq / 50 ml Peripheral line administration Maximum rate: 10 meq IV over 1 hour Maximum concentration: 10 meq / 50 ml Magnesium IV Protocols Have a previous level from within 24 hours May recheck a level 2 hours after administration Central or peripheral line administration Maximum rate: 2 grams IV over 1 hour Maximum concentration: 2 grams / 50 ml Phosphorus IV Protocols Have a previous level from within 24 hours May recheck a level 2 hours after administration Should be ordered in mmol of phosphorus Approximately 1 mmol phosphate = 1.5 meq potassium (in KPO 4 ) Use sodium phosphate for patients with: Serum potassium >4.5 meq/l & serum sodium <145 meq/l Central line administration Maximum rate: 15 mmol / 100 ml IV over 2 hours Peripheral line administration Maximum rate: 15 mmol / 250 ml IV over 4 hours 10

Calcium IV Protocols Have a previous level from within 24 hours May recheck a level 2 hours after administration Administer through central line (highly preferred) Central or peripheral line administration Maximum rate: 2 grams IV over 1 hour Maximum concentration: 2 grams / 100 ml Conclusion Electrolytes are considered high alert medications We need to order, prepare, dispense, and administer electrolyte solutions with caution Stocking and carrying manufactured electrolyte solutions can help reduce errors Creation of protocols and use of standardized order sets are good ways to avoid errors Learn from near misses and errors to create safer practice in the future Questions? Jennifer Doughty, Pharm.D. jedought@stormontvail.org 11

References Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34 Cohen MR, Smetzer JL, Tuohy NR, Kilo CM. High-alert medications: safeguarding against errors. In: Cohen MR, ed. Medication Errors. 2nd ed. Washington, DC: American Pharmacists Association; 2007. Control of concentrated electrolyte solutions. The World Health Organization. http://www.who.int/patientsafety/solutions/patientsafety/ps-solution5.pdf. Published May 2007. Accessed August 1, 2017 Engels MJ, Ciarkowski SL. Nursing, Pharmacy, and Prescriber Knowledge and Perceptions of High-Alert Medications in a Large, Academic Medical hospital. Hospital Pharmacy. 2015; 504(4): 287-295. doi:10.1310/hpj5004-287. ISMP List of High-Alert Medications in Acute Care Settings. Institute for Safe Medication Practices. https://www.ismp.org/tools/institutionalhighalert.asp. Accessed August 1, 2017. Pharmacy automatic electrolyte adjustment protocol in critical care. Stormont Vail Health. Revised September 16, 2014. Accessed August 1, 2017. Potassium may no longer be stocked on patient care units, but serious threats still exist. Institute for Safe Medication Practices. https://www.ismp.org/newsletters/acutecare/articles/20071004.asp. Published October 4, 2007. Accessed August 1, 2017. Reduce adverse drug events Involving electrolytes. Institute of Healthcare Improvement. http://www.ihi.org/resources/pages/changes/reduceadversedrugeventsinvolvingelectrolytes.aspx. Accessed August 1, 2017. Survey suggests possible downward trend in identifying key drugs/drug classes as high-alert meedications. Institute for Safe Mediation Practices. https://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=83. Published July 3, 2014. Accessed August 1, 2017. 12